exploring the potential impact of art in reducing hiv transmission
DESCRIPTION
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London. Contents. Potential impact of increased treatment at CD4 < 200 and < 350 on spread of infection. - PowerPoint PPT PresentationTRANSCRIPT
Exploring the potential impact of ART in reducing HIV transmission.
Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin
Imperial College London
Contents
• Potential impact of increased treatment at CD4 < 200 and < 350 on spread of infection.
• Potential impact of pre-exposure prophylaxis (PrEP).• When treatment and when PrEP?
Factors decreasing the role of later stages of HIV infection and the potential of treatment to reduce
transmission
• Rapid spread and saturation of HIV in the at risk population (i.e. little ongoing spread of infection).
• Decreasing number of contacts as a function of time since infection - 1) concurrency leads to more potential contacts early infection; 2) people reducing numbers of partners over time; 3) Saturation in age cohorts
• Poor adherence; poor suppression of viral load; treatment failure and resistance.
• Slower progression to low CD4 counts.• Increased risk behaviour of those on treatment.• Increased risk behaviour amongst those not on treatment –
including susceptibles.
Model - Eaton et al AIDS & Behaviour (In Press):
Transmission model (Stochastic individual based) representing generalised heterosexual epidemic – including:
• concurrency in sexual partnerships; • Heterogeneity in propensity to acquire new
partnerships; • Transmission risk within partnerships as a function of
time since infection. • Movement from high activity to moderate activity and
moderate activity to low activity over time.
Population size 50,000; seed 1% prevalence; results average of 100 runs.
Transmission risk by stage of HIV infection
Proportion of infections generated as a function of time since infection.
Proportion of transmission by stage of infection as epidemic progresses.
Population size 50,000; seed 1% prevalence; results average of 100 runs.
Generalised epidemic – concurrency driving epidemic CD4< 350 after mean 4.5 years
Slower progression to CD4 <350 More infections in earlier stages.Mean duration to <350 7 years.
Epidemic drive by small (2%) high risk group (prevalence 1.5%) More sensitive to movement from high to low risk.
PrEP model developed by Tim Hallett and Ide Cremin
The first model of PrEP for West Africa
Detailed Representation of PrEP• Detailed patterns of adherence• Targeting• Duration on PrEP
PrEP in Combination Prevention» Treatment for clinical need» Increases in condom use & reductions in numbers of partners» ‘Early’ treatment initiation
The model captures many important features of HIV transmission in Cotonou:
The Mathematical ModelPrEP for prevention – preliminary results
Sex workersRegular clients
WomenMen
Coverage, Adherence & DurationPrEP for prevention – preliminary results
“Optimistic” “Realistic”
Coverage Uniform with respect to risk group and gender
Uniform with respect to risk group and gender
% of PrEP users with good adherence
80% 50%
Mean duration on PrEP
10 years 5 years
Years to reach coverage
2 years 5 years
“Optimistic”
“Realistic”
Effective TargetingFor the same number of people staring PrEP, effective targeting to those at most risk can substantially amplify impact.
10% of population start PrEP
Good Targeting
No Targeting
Some Targeting
PrEP in Combination Prevention
Status quo
Intervention to scale (incr. condom use and prompt treatment initiation)
+ Targeted effective PreP
+ The missing piece?
Numbers based on extrapolation to Urban Benin; *PreP intervention is to 60% of sex workers & clients; 70% efficacy and 80% adherence, for 10 years. ** The missing piece required to reduce incidence by 90% in 2031 and eventually stop the epidemic is a 60% efficacy vaccine delivered to half the population.
Discord CD4>350 New infections0
40
80
120
Num
ber (
thou
sand
s)
CD4>350
Discord CD4>200 New infections0
40
80
120
Num
ber (
thou
sand
s)
CD4>200
Sexually active Susceptible Stable partner Discordant0
1000
2000
3000
4000
Num
ber (
thou
sand
s) 52%*
13%**
91%*
0 20 40 60 80 1000
5
10
15
20
25
PrEP effectiveness in couples (%)
Cum
ulat
ive
risk
of in
fect
ion
ART initiation at CD4<350
PrEP and ART initiation at CD4<200
Domain where PrEP averts more infections that treatment in couples. Need PreP effectiveness>60%
0 20 40 60 80 1000
5
10
15
20
25
PrEP effectiveness in couples (%)
Cum
ulat
ive
risk
of in
fect
ion
PrEP and ART initiation at CD4<350
ART initiation immediately
Domain where PrEP averts more infections that treatment in couples. Need PreP effectiveness>85%
Conclusions
• Good coverage of those with CD4 < 200 could avert around 25% of new infections and with CD4 < 350 a further 15% could be averted.
• Reductions in risk behaviour associated with treatment could improve this; increases in risk behaviour could undermine it.
• PrEP can reduce incidence but needs high efficacy, coverage and adherence - and needs appropriate targeting to be efficient.
• Earlier treatment reduces role of PrEP; its effectiveness per partnership relative to treatment of the infected partner determines how useful it would be in discordant couples.